A detailed history of Octavia Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Octavia Wealth Advisors, LLC holds 1,241 shares of AMGN stock, worth $385,665. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,241
Previous 2,278 45.52%
Holding current value
$385,665
Previous $656,000 46.34%
% of portfolio
0.05%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$268.87 - $324.56 $278,818 - $336,568
-1,037 Reduced 45.52%
1,241 $352,000
Q4 2023

Jan 30, 2024

SELL
$255.7 - $288.46 $5,625 - $6,346
-22 Reduced 0.96%
2,278 $656,000
Q3 2023

Oct 30, 2023

BUY
$218.65 - $271.46 $15,524 - $19,273
71 Added 3.19%
2,300 $618,000
Q2 2023

Jul 18, 2023

BUY
$214.27 - $253.37 $237,196 - $280,480
1,107 Added 98.66%
2,229 $494,000
Q1 2023

Apr 20, 2023

BUY
$225.79 - $275.2 $14,902 - $18,163
66 Added 6.25%
1,122 $271,000
Q4 2022

Jan 19, 2023

BUY
$229.03 - $291.01 $22,215 - $28,227
97 Added 10.11%
1,056 $0
Q3 2022

Oct 17, 2022

BUY
$224.46 - $253.15 $2,469 - $2,784
11 Added 1.16%
959 $216,000
Q2 2022

Jul 18, 2022

SELL
$230.71 - $256.74 $2,307 - $2,567
-10 Reduced 1.04%
948 $230,000
Q1 2022

Apr 20, 2022

SELL
$219.27 - $242.57 $214,884 - $237,718
-980 Reduced 50.57%
958 $232,000
Q4 2021

Jan 28, 2022

BUY
$198.88 - $227.6 $385,429 - $441,088
1,938 New
1,938 $436,000
Q2 2021

Jul 26, 2021

SELL
$233.58 - $259.14 $396,618 - $440,019
-1,698 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$221.91 - $258.6 $14,646 - $17,067
-66 Reduced 3.74%
1,698 $422,000
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $381,694 - $454,529
1,764 New
1,764 $406,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Octavia Wealth Advisors, LLC Portfolio

Follow Octavia Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octavia Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Octavia Wealth Advisors, LLC with notifications on news.